Core Viewpoint - Ardent Health, Inc. is facing a federal securities class action lawsuit due to allegations of misleading investors regarding its accounts receivable collectability practices, with a deadline for lead plaintiff applications set for March 9, 2026 [1][3]. Group 1: Lawsuit Details - The lawsuit pertains to investors who acquired Ardent securities between July 18, 2024, and November 12, 2025, during which the company allegedly misrepresented its monitoring process for accounts receivable [3]. - Ardent claimed to use detailed reviews of historical collections to assess collectability, but it actually relied on a 180-day cliff method, which allowed for inflated accounts receivable reporting and delayed loss recognition [3]. Group 2: Financial Impact - On November 12, 2025, Ardent disclosed a $43 million revenue reduction due to changes in accounting estimates for accounts receivable collectability and a $54 million increase in professional liability reserves related to New Mexico claims [4]. - Following this announcement, Ardent's share price fell by $4.75, or approximately 33.8%, from $14.05 to $9.30 per share [4].
REMINDER: Ardent Health, Inc. Investors With Significant Losses Must Act By March 9, 2026